Our Blog
Insights on regulatory affairs, quality, pharmacovigilance and RNA technologies from the Molgenium team.
Featured Post
The Arab GVP Gap: Why Pharmacovigilance in the Arab World Can't Run on Imported Systems
By Dr. Mohamad Toutounji
Oct 01, 2026
Advanced Therapies (ATMPs & mRNA)
How to Define Clinically Relevant Specifications for mRNA Products
By Dr. Mohamad Toutounji
Mar 21, 2026
Training & Careers
AI Literacy Belongs in Your Training Matrix
By Dr. Mohamad Toutounji
Oct 06, 2026
Tech Transfer & Manufacturing
Tech Transfer Without Tears: A Phase-by-Phase Playbook
By Dr. Mohamad Toutounji
Oct 05, 2026
Regulatory Strategy
The EU Pharma Package Is Almost Law: What Changes for Marketing Authorisation Holders
By Dr. Mohamad Toutounji
Oct 02, 2026